Department of Pathology (Division of Anatomic Pathology)

Experimental Therapeutics Cancer Center Program

Molecular Oncology Diagnostics, ARUP Laboratories (Medical Director)

Breast Cancer Disease-Oriented Team

Prostate Cancer Disease-Oriented Team

bernard lab banner

Principal Investigator - Phil Bernard

phil bernard

Phil Bernard, MD

Cancer Center Bio

Selected Achievements

Siemens Westinghouse Outstanding Mentor (2003)

Technology Innovation Award, Rapid DNA Analysis Technologies (2004)

Philip Bernard, MD, is an associate professor of pathology at the University of Utah School of Medicine, medical director of Molecular Oncology Diagnostics at ARUP Laboratories, and a Huntsman Cancer Institute investigator. He is a member of the Experimental Therapeutics Program.

Bernard's research focuses on molecular classifications of tumors for the prognosis and treatment of cancer. This includes predicting response to therapy and monitoring residual disease. Using cutting-edge technology such as microarray, real-time polymerase chain reaction, and laser-capture microdissection, his lab correlates clinical behavior of tumors with molecular features.

Bernard received his medical degree from the University of Utah in 1996. He also completed postdoctoral training and a clinical residency at the University of Utah. He joined Huntsman Cancer Institute in 2002.